As of May 2024 Immunovant has a market cap of $4.42 Billion. This makes Immunovant the world's 2873th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $4.42 B | -27.34% |
2023 | $6.09 B | 165.79% |
2022 | $2.29 B | 134.02% |
2021 | $0.97 B | -78.33% |
2020 | $4.52 B | 421.29% |
2019 | $0.86 B |
On May 14th, 2024 the market cap of Immunovant was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.61 B | -86.16% | ๐บ๐ธ USA |